Fig. 3From: Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysisComprehensive ranking (efficacy and tolerability) of front-line treatments in newly diagnosed CP-CML. (Efficacy is evaluated as MMR within 12 months and tolerability is evaluated as less discontinuation for drug-related AEs)Back to article page